The open book of infectious diseases

The open book of infectious diseases

New classes of chemical compounds along with more efficient methods to identify drug targets have produced exciting developments in antituberculous antibiotics. Will the new drugs now entering clinical trials have an impact on treatment?

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature medicine 2007-03, Vol.13 (3), p.279-280
Hauptverfasser: Sassetti, Christopher M, Rubin, Eric J
Format: Artikel
Sprache:eng
Schlagworte:
Antibiotics
Antibiotics, Antitubercular - therapeutic use
Biomedical and Life Sciences
Biomedicine
Cancer Research
Chemical compounds
Communicable Disease Control - trends
Drug therapy
Forecasting
Humans
Infectious Diseases
Medical research
Metabolic Diseases
Molecular Medicine
Neurosciences
news-and-views
Tuberculosis
Tuberculosis, Pulmonary - drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:New classes of chemical compounds along with more efficient methods to identify drug targets have produced exciting developments in antituberculous antibiotics. Will the new drugs now entering clinical trials have an impact on treatment?
ISSN:1078-8956
1546-170X
DOI:10.1038/nm0307-279